Recent news from the Fuhrmann Lab

Manuscript in Advanced Materials, February 2018


BION has recently published the first example of incorporation of extracellular vesicles into a biomedical hydrogel.


Hydrogels were characterised biomechanically and employed for an enzyme-prodrug therapy approach showing enhanced anti-inflammatory activity.

BION Christmas lunch, December 2017


After completing a team exercise in the morning, we went out for our annual Christmas lunch. It took place in the restaurant "Herzenslust" in the centre of Saarbrucken! 


Afterwards, we had another mulled wine at the Saarbrucken Christmas market.


Thanks for participating everyone!

VW grant Experiment!, November 2017


BION receives a grant from the Volkswagen Stiftung. Their programme Experiment! is designated for exploring highly risky research ideas. We aim at developing novel cell-mimetics for modulating autoimmune diseases.


This is an enormous achievement as the success rate for this programme was below 5%!

Galenus Award ceremony, November 2017


Gregor receives the Galenus Technology Award from the Galenus Privatstiftung 2017.


The award ceremony took place in the Natural History Museum in Vienna (Austria). The perfect location for a prestigious prize!

Scholarship for Maximilian Richter, November 2017


Max Richter has secured funding from the German Studienstiftung des deutschen Volkes.


His fellowship will support his PhD work in the BION group.


Well done, Max!

PhD seminar, October 2017


BION had their PhD seminar together with the groups of Claus-Michael Lehr (HIPS) and Marc Schneider (Uni Saarland).


We enjoyed two days of science discussion and social activities, such as our volleyball tournament!

BION retreat, August 2017


BION has recently been on their annual group retreat enjoying a full day of discussing science and other social activities.


We went to an Escape room to hunt for Jack the Ripper! Fortunately, we managed to escape the room within the one hour time limit.


Good job, folks!

Galenus Technology Award, August 2017


Gregor has been awarded the prestigous Technology Prize from the Galenus Privatstiftung. The award recognises Gregor's contribution to the field of Pharmaceutical Technology.


He will receive the award in Vienna in November 2017 and together with the second winner, Dr. Peter Wich (University Mainz).

Scholarship for Mina Mehanny, July 2017


Mina Mehanny has recently secured a competitive German Egyptian research longterm scholarship from the German Academic Exchange Service DAAD.


With this fellowship, Mina will take up his PhD studies in the BION group starting in April 2018.


Congratulations, Mina!

Manuscript in COCIS, July 2017


In our recently published review manuscript in Current Opinion in Colloid and Interface Science (COCIS) we discuss new strategies of improving oral delivery of various drugs by means of polymer conjugation. We highlight the importance of such macromolecular conjugates as promising avenue for the oral administration route.


Visit EU Commissioner, Mai 2017


The European Commissioner for Health and Food Safety, Vytenis Andriukaitis, has recently visited the Helmholtz-Institute for Pharmaceutical Research.


Read more about his visit at HIPS here


Portrait in InFact, April 2017


Gregor has been recently portrayed in the staff magazin InFact from the Helmholtz-Centre for Infection Research.


Read more on his scientific career and why he is a supporter of Hertha BSC.


Exam ceremony, April 2017


Gregor has recently given the key note lecture at the exam ceremony of the Pharmaceutical Institute at Johannes Gutenberg University Mainz.


Learn more on recent therapeutic approaches on celiac diseases here.


March for Science, April 2017


BION has participated in the March for Science 2017.


We stand for equality, because no matter what gender we will not surrender!


More here


Manuscript in EJPB, April 2017


Our lab has recently published a review manuscript in the European Journal of Pharmaceutics and Biopharmaceutics (EJPB).

The paper discusses the role of extracellular vesicles in infections and their potential use for therapy. This work was a collaboration with the pARTicles 3D Lab at EMPA, Switzerland (Dr. Inge K. Herrmann)


German Society for Extracellular Vesicles, March 2017


The German Society for Extracellular Vesicles is the national network for scientists and professionals working in the field of exosomes, microvesicles and other cell-derived vesicles. Gregor is a founding member of GSEV.  More at or by contacting Gregor Fuhrmann



Press release GSEV
PDF-Dokument [361.6 KB]

Fuhrmann lab in Campus Magazine, February 2017


Read the latest article about our work in Campus, the Web-Magazine from the Saarland University and learn how we develop "nanoparticle-taxis" to deliver antibiotics to the site of infection.


Full Campus article here

Fuhrmann lab in the news, December 2016


Our research group has recently been featured in the broadcast programme Aktueller Bericht from the SR Television. The report gives an overview of our scientific profile and outlines the potential of biomimetic systems in infection research.


See the video here (starts at 22:18 min).

NanoMatFutur Junior Research Group, December 2016


Gregor Fuhrmann has received a prestigious research grant from the German Federal Ministry of Education and Research (BMBF). His project will focus on a novel natural transport system for antibiotics and is funded for 5 years.


Helmholtz Association press release.

Poster award, September 2016


Gregor Fuhrmann has won the Best poster award at the Nano meets Future Symposium, Saarbrücken, Germany, for his work entitled "Extracellular vesicles as smart carriers for small molecule drugs.


Helmholtz-Centre for Infection Research


Helmholtz-Institute for Pharmaceutical Sciences Saarland (HIPS)


Saarland University Campus E8.1
66123 Saarbrücken


Our research is supported by the NanoMatFutur programme from the Federal Ministry of Education and Research (BMBF). Project BEVA

Druckversion Druckversion | Sitemap
© Gregor Fuhrmann Powered by 1&1